News: Home Page Latest News

Next Page »« Previous Page

National Cancer Act 40th Anniversary

Friday, December 23rd, 2011

In the 40 years since President Nixon “declared war” on cancer, much progress has been made. We are screening more, catching cancers sooner, using DNA information to tailor treatment to the individual. Still, cancer is responsible for one in four deaths in the United States.

VICC Named to Proteomic Cancer Research Consortium

Thursday, December 8th, 2011

A team of Vanderbilt-Ingram Cancer Center scientists, led by Daniel Liebler, Ph.D., professor of Biochemistry, Biomedical Informatics and Pharmacology, has been selected to participate in the Clinical Proteomic Tumor Analysis Consortium (CPTAC), a multi-center cancer research program created by the National Cancer Institute (NCI). Liebler will lead the Vanderbilt Proteome Characterization Center, one of five […]

MyCancerGenome Finalist for Tech Award

Friday, October 28th, 2011

MyCancerGenome, the online medical decision support tool for cancer care developed by Vanderbilt physician-scientists, has been selected as a finalist for a health care technology award. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” is sponsored by the National Cancer Institute (NCI), Division of Cancer Control and […]

Nolan Weathers Cancer’s Storms

Friday, October 21st, 2011

As a veteran meteorologist for WKRN Channel 2 in Nashville, Davis Nolan is an expert at diagnosing weather patterns that can create violent winds and thunderous storms. But he had no hints about the potentially deadly storms that were brewing inside his own body until a routine visit to his primary care physician led to […]

Arteaga Earns Komen Award

Friday, October 7th, 2011

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the winners of this year’s Susan G. Komen for the Cure Brinker Awards for Scientific Distinction. The Brinker Awards for Scientific Distinction were established in 1992 to recognize the efforts of […]

Pao to Lead Hematology and Oncology

Friday, September 23rd, 2011

William Pao, M.D., Ph.D., associate professor of Medicine and director of Personalized Cancer Medicine at Vanderbilt, has been named director of the Division of Hematology and Oncology in the Department of Medicine. “Dr. Pao has demonstrated tremendous leadership and creativity since arriving at Vanderbilt,” said Nancy Brown, M.D., chair and physician-in chief of the Department […]

VICC Solidifies Research Administration

Friday, September 2nd, 2011

Lauren Hackett, MPA, has been named executive director for cancer research administration at Vanderbilt-Ingram Cancer Center. Hackett has 19 years of experience in research administration, most recently at New York University Cancer Institute, where she has served as executive director for administration since 2004. She held similar roles with the Yale School of Medicine and […]

Cancer Center Debuts Clinic in Green Hills

Friday, August 19th, 2011

Vanderbilt-Ingram Cancer Center has opened a free-standing cancer clinic in Green Hills to give cancer patients more options for their oncology care. VICC Green Hills provides many of the same services available at the main VICC campus, including access to board-certified cancer physicians and specially trained oncology nurses and pharmacists. Patients can see an oncologist, […]

‘Bright Day for Many Melanoma Patients’

Thursday, August 18th, 2011

News that the Food and Drug Administration had approved a new targeted drug for advanced melanoma was heralded as good news this week by physician-scientists at Vanderbilt-Ingram Cancer Center, which was involved in many of the studies that helped lead to the approval. “This is a bright day for many melanoma patients,” said Dr. Jeffrey […]

Breast Cancer Added to Gene Test Arsenal

Friday, July 8th, 2011

Breast cancer patients at Vanderbilt-Ingram Cancer Center can now have their tumor tissue tested for gene mutations that are important for treatment decisions. Information from genetic tests in the tumors will be used to match patients to the best cancer therapies available, including drugs that are in early clinical trial testing. Tumor mutation testing for […]